Inflammation memories in our skin might hold the key to comprehending psoriasis better.
In a groundbreaking discovery, researchers have uncovered that chronic inflammation significantly impacts the regenerative properties of skin stem cells, with far-reaching implications for various diseases such as inflammatory bowel disease (IBD), asthma, multiple sclerosis, and even cancer. Moreover, this finding sheds light on the development of chronic inflammatory disorders like psoriasis.
Skin regeneration following injury is a finely tuned process, involving skin stem cells that proliferate and differentiate to restore tissue integrity. However, during inflammation, the immune system releases cytokines and pro-inflammatory mediators that alter the microenvironment, disrupting the normal function of skin stem cells and impairing their ability to proliferate and differentiate effectively. This results in delayed wound healing and aberrant skin regeneration, often accompanied by excessive fibroblast activity and prolonged presence of pro-inflammatory immune cells.
Psoriasis, a chronic inflammatory skin disorder, is characterized by excessive keratinocyte proliferation and infiltration of inflammatory cells, driven primarily by cytokines associated with the IL-23/Th17 axis, such as IL-23, IL-17, and IL-22, as well as tumor necrosis factor-alpha (TNF-α) and interferon-gamma (IFN-γ). These cytokines create an altered stem cell niche that promotes pathological renewal and differentiation pathways in keratinocytes, rather than normal regeneration. Additionally, chronic inflammation maintains a pool of pathogenic T cells that contribute to disease relapse when treatment is discontinued.
Therapeutic strategies that modulate inflammation and restore stem cell function offer promise for improving outcomes in such disorders. Mesenchymal stem cells (MSCs) have shown potential in modulating inflammation and enhancing wound healing by promoting anti-inflammatory macrophage polarization and regulating T cell responses. MSC-based therapies are being explored in clinical trials for immune-mediated inflammatory skin diseases, including psoriasis, showing promising partial to complete remission in some cases with relatively mild adverse events.
Biologic treatments that target cytokines like TNF-α, IL-17, and IL-23 are effective but have limitations such as relapse upon discontinuation, highlighting the importance of controlling inflammation to maintain stem cell function and skin homeostasis. The study challenges the traditional approach to treating psoriasis, which primarily targets the immune system, by suggesting that future therapies might aim to reset or erase the inflammatory memory held by stem cells.
Intriguingly, the study found that the gene Aim2 becomes more "open," making it easier to activate quickly in the future, after an inflammatory event. These changes involve altering the accessibility of certain genes, particularly those associated with inflammation. The study suggests that even if the immune system is calmed down, the skin's memories could still cause inflammation to return. The rapid-healing trick in skin, while amazing in normal circumstances, turns destructive in conditions like psoriasis.
Each time an inflammatory event occurs, the skin stores data and prepares for future similar events, which could lead to excessive protection in non-threatening situations. This memory helps the skin heal faster the next time around. However, the key player in this process is a gene called Aim2, which is activated during the first inflammatory event and stays ready for future activation. The Rockefeller team's findings suggest that stem cells with a "memory" of inflammation may be over-primed, leading to aggressive reactions even when there's no clear threat.
The study highlights the remarkable biological hack that allows us to bounce back faster from injury, but also underscores the potential costs of this power. The skin's ability to learn, adapt, and evolve based on past inflammatory events could change everything we thought we knew about chronic inflammation, psoriasis, and the secret life of our skin. Scientists discovered that stem cells in human skin "log" past inflammatory events, which could pave the way for new therapeutic strategies to tackle chronic inflammatory disorders like psoriasis more effectively.
- The findings of the study on psoriasis reveal that chronic inflammation leads to an altered stem cell niche in skin, causing pathological renewal and differentiation pathways in keratinocytes in skin-conditions like psoriasis.
- The discovery of the skin's memory in response to past inflammatory events suggests that stem cells could be over-primed, leading to aggressive reactions in health-and-wellness conditions such as psoriasis.
- In the realm of health-and-wellness, therapeutic strategies that modulate inflammation and restore stem cell function, such as those using mesenchymal stem cells, hold promise for improving outcomes in medical-conditions like psoriasis.
